AstraZeneca PLC
9 March 2001
ASTRAZENECA PLC ANNOUNCES PUBLICATION OF 2000 ANNUAL REPORT, ANNUAL REVIEW AND
AGM DOCUMENTS AND RETIREMENT OF SIR DAVID BARNES CBE
AstraZeneca PLC announces that today, 9 March 2001, it has published its 2000
Annual Report, Annual Review and Notice of Annual General Meeting. The AGM is
to be held on 26 April 2001.
With effect from the date of the AGM, Sir David Barnes CBE - currently
Non-Executive Deputy Chairman - will retire from the Board of Directors of the
Company after more than 14 years' service as a Director of Imperial Chemical
Industries PLC, Zeneca Group PLC and AstraZeneca PLC.
G H R Musker
Company Secretary
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.